Generalized Chemicals To predict biofilm inhibition efficacy of chemical(s) |
Pseudomonas aeruginosa (Species-Specific Predictor) To predict biofilm inhibition efficacy of chemical(s) against P. aeruginosa (Gram -ve & ESKAPE bacteria) |
Gram-positive bacteria (Group-Specific Predictor) To predict the biofilm inhibition efficacy of chemical(s) against Gram-positive bacteria |
Staphylococcus aureus (Species-Specific Predictor) To predict biofilm inhibition efficacy of chemical(s) against S. aureus (Gram +ve & ESKAPE bacteria) |
Gram-negative bacteria (Group-Specific Predictor) To predict the biofilm inhibition efficacy of chemical(s) against Gram-negative bacteria |
Escherichia Coli (Species-Specific Predictor) To predict biofilm inhibition efficacy of chemical(s) against E. coli (Gram -ve & model bacteria) |
Fungus or Yeast (Group-Specific Predictor) To predict the biofilm inhibition efficacy of chemical(s) against Fungus or Yeast |
Candida albicans (Species-Specific Predictor) To predict biofilm inhibition efficacy of chemical(s) against C. albicans (fungus or yeast) |
Antibiotic resistance has emerged as a major public health threat globally in both developing as well as the developed countries and without multi pronged interventions its status is going to worsen in future as per World Health Organization, (http://www.who.int/mediacentre/factsheets/antibiotic-resistance/en/). Leading cause of drug resistance is the growth of microorganisms in biofilm mode. Biofilms are colonized behaviour of microbes, where a unicellular bacteria mimics multicellular lifestyle by undergoing division of labour. Planktonic bacteria go through various modifications to withstand unfavourable conditions (like antibiotics) by transforming in a self-secreted cocoon called biofilm. The biofilms are evident to be 10-1000 folds more resistant towards antibiotics. Anti-biofilm agents can disrupt the biofilms and can also enhance the conventional antibiotics through synergistic effects similar to adjuvants increasing the efficacy of vaccines. Anti-biofilm agents even demonstrated greater promises by killing the Multidrug-resistant strains including ESKAPE pathogens (Carol Potera 2010).
Researchers have been working hard to develop various anti-biofilm agents from last three decades due to their immense therapeutic potential. However computational resources in this important field are absolutely lacking. To fill this void, we have recently developed a resource of anti-biofilm agents called “aBiofilm” that harbors 1720 unique anti-biofilm agents among 5027 entries (Rajput A et al 2018) targeting 140 micro-organisms. It also provides a simplified classification based prediction tool for identification of anti-biofilm agent. However, there is an urgent need to develop comprehensive web server to predict the anti-biofilm activity of chemical(s) and peptides to speed up the research in the area.
In this endeavour, we have now developed Biofilm-i, a platform to predict the biofilm inhibiting efficacy of chemical(s) and peptide(s) using Quantitative structure–activity relationship (QSAR) based regression models.
Following are the salient features of our web server:
Biofilm-i, is the first regression based portal for the prediction of biofilm inhibition of chemical(s). This web server will help the wider scientific community to speed up research to tackle the menace of Antibiotic drug resistance.
PhD Scholar
Project Assistant- II
Senior Scientist